Drawing for AGLAIA

USPTO serial 85335395

AGLAIA

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
FENNESSY, EDWARD JOHN
Law office
TMEG LAW OFFICE 101

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with AGLAIA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jeffrey H. Kaufman

Jeffrey H. Kaufman OBLON, MCCLELLAND, MAIER & NEUSTADT, LLP1940 DUKE STREETALEXANDRIA, VA 22314-3451UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Reagents for medical and clinical diagnosis purposes; medicines for in-vitro diagnosis; reagents for medical and veterinary genetic testing; medical diagnostic reagents comprised of genetic chips for clinical diagnosis; reagents for medical treatment purposes, namely, for detecting gene polymorphisms; reagents for medical treatment purposes, namely, for DNA extraction; reagents for medical treatment purposes, namely, for DNA amplification; reagents for medical treatment purposes, namely, for selecting best course medical treatment including identifying infectious agents, vulnerability against specific disease, and selecting most effective and least adverse effect medicine; reagents for gene analysis for medical treatment purposes, namely, for selecting best course medical treatment including identifying infectious agents, vulnerability against specific disease, and selecting most effective and least adverse effect medicineACTIVE—
009DNA chips for medical diagnosis; computer software for genetic analysis for medical purposes; computer software for use in medical testing and diagnosis, namely, computer software for detecting single-nucleotide polymorphisms, somatic mutations and specific sequences for medical diagnosisACTIVE—
010In vitro analysis apparatus and instruments primarily for detecting single-nucleotide polymorphisms, somatic mutations and specific sequences; medical diagnostic apparatus for determining appropriate medical treatment based on genetic analysis of patient morbidity and physical condition; clinical chemical analysis devices comprising automatic dispensers, DNA extracting units, fluorescent detecting units and thermostats; medical diagnostic apparatus comprised primarily of DNA chips and DNA extracting cartridges for genetic analysis of patients; medical diagnostic apparatus for the genetic analysis of single-nucleotide polymorphisms, somatic mutations, nucleic acids, proteins, chemical compounds, oligonucleotides, and polypeptides samples; medical diagnostic apparatus for the genetic analysis of biological matter extracted from humans and animalsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
May 9, 2016MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 9, 2016ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 15, 2015EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 14, 2015EX5GSOU EXTENSION 5 GRANTED—
Oct 13, 2015AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Sep 30, 2015EXT5SOU EXTENSION 5 FILED—
Sep 30, 2015EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 25, 2015EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 24, 2015EX4GSOU EXTENSION 4 GRANTED—
Feb 3, 2015EXT4SOU EXTENSION 4 FILED—
Feb 3, 2015EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 3, 2015TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 20, 2014EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 19, 2014EX3GSOU EXTENSION 3 GRANTED—
Sep 11, 2014EXT3SOU EXTENSION 3 FILED—
Sep 11, 2014EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 18, 2014EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 17, 2014EX2GSOU EXTENSION 2 GRANTED—
Apr 14, 2014AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Mar 20, 2014EXT2SOU EXTENSION 2 FILED—
Mar 20, 2014EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 25, 2013EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 23, 2013EX1GSOU EXTENSION 1 GRANTED—
Jul 23, 2013EXT1SOU EXTENSION 1 FILED—
Jul 23, 2013EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 2, 2013NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 5, 2013NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 5, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 16, 2013NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 3, 2013PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 2, 2013EXPTEXPARTE APPEAL TERMINATED—
Jan 2, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 14, 2012TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 14, 2012CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 9, 2012ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Nov 9, 2012EXPIEX PARTE APPEAL-INSTITUTED—
Nov 9, 2012JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY—
Nov 9, 2012EXAFEXPARTE APPEAL RECEIVED AT TTAB—
May 9, 2012GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
May 9, 2012GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 9, 2012CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 12, 2012TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 12, 2012CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 12, 2012TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 30, 2012ALIEASSIGNED TO LIE—
Mar 23, 2012PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Mar 16, 2012CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 16, 2012TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 16, 2011GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 16, 2011GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 16, 2011CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 16, 2011DOCKASSIGNED TO EXAMINER—
Jun 6, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 4, 2011NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance